tag:blogger.com,1999:blog-3983381501063459264.post8769747571016056126..comments2011-12-13T16:51:00.137-05:00David W. Zollhttp://www.blogger.com/profile/06121558122495103952noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-3983381501063459264.post-82599012245417691632011-12-13T16:51:00.137-05:002011-12-13T16:51:00.137-05:00We believe that the required label change will ultimately have a strong positive effect on the ongoing Yaz litigation. We applaud the FDA Advisory Panel’s decision to change the wording, as Zoll, Kranz and Borgess has consistently argued that Bayer’s current labeling fails to adequately warn women about the serious dangers of Drospirenone-containing oral contraceptives, including significant increased risks of blood clots and stroke.Anneke Kurthttp://www.blogger.com/profile/15574014834410348945noreply@blogger.comtag:blogger.com,1999:blog-3983381501063459264.post-5669595300023174592011-12-09T13:35:56.238-05:002011-12-09T13:35:56.238-05:00so since the FDA is only requiring stronger labels, what does this mean to the litigation?Anonymousnoreply@blogger.com